Signaling Pathways - Hepatitis C - Non-small Cell Lung Carcinoma - Immunosuppressive Therapy - Cholangiocarcinoma
清除全部
-
B2178 BAY 80-6946 (Copanlisib)1 Citation中文名: 库潘尼西Target: PI3KSummary: PI3K抑制剂 -
A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb（P糖蛋白）抑制剂 -
A8477 MK-8776 (SCH-900776)Target: ChkSummary: Chk1高效选择性抑制剂 -
A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂 -
A3820 Simeprevir1 Citation中文名: 西咪匹韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂 -
A3655 NesbuvirTarget: Nonstructural protein 5B (NS5B)Summary: NS5B聚合酶选择性抑制剂 -
A3573 LY2801653Target: METSummary: MET抑制剂 -
A3191 Ascomycin(FK 520)中文名: 长川霉素Target: phosphatasesSummary: FK-520 类似物，大环内酯类免疫抑制剂 -
A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂 -
A4031 Telaprevir (VX-950)中文名: 特拉匹韦Target: HCV NS3-4A proteaseSummary: HCV NS3-4A蛋白酶抑制剂